For globally-acting companies, REACH is not the only regulatory challenge – it’s just the tip of the iceberg. Knoell´s conference on global chemical regulations provided an overview about the recent status and developments in chemical regulations, particularly in Asia and the Americas.
This event features conference presentations covering market trends in the agrochemical and speciality chemical industries, alongside more than 225 exhibitor displays and company showcase presentations.
In the first week of July, the FDA released a statement by its Commissioner Scott Gottlieb, MD, on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs. A copy of the statement is provided below. Statement by FDA Commissioner, Dr Scott Gottlieb
The 48th Silicon Symposium returned to Philadelphia in June to continue the long tradition of connecting academia and industry, and to discuss latest developments and new applications in silicon chemistry.
Johnson Matthey, a global leader in science that enables cleaner air, improved health and more efficient use of natural resources, and Intrexon, a leader in the engineering and industrialization of biology, have entered into an exclusive collaboration to focus on the development of fermentation processes to produce peptide-based APIs. Peptide-based active pharmaceutical ingredients (APIs) are used as highly effective treatments in numerous therapeutic classes. However due to their structural complexity, peptides are costly and difficult to produce, requiring specialized equipment and reagents, and lengthy synthetic sequences with low chemical yields. To address this, Intrexon will focus on strain generation, utilizing its proprietary microbial hosts, initial fermentation and downstream isolation and purification. Subsequently, Johnson Matthey will be responsible for product scale-up and commercialization, ultimately developing much more efficient and effective processes for peptide-based drugs.
Flamma, a family-owned CMO that develops, manufactures, and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, celebrated the Grand Opening of its new cGMP workshop and R&D Centre in Dalian, China on 19th June.
In response to the significant growth trajectory anticipated in the global polyisobutylene (PIB) market, ChemSpec (Uniontown, OH), a member of the Safic-Alcan Group family of companies, continues to expand its portfolio to a range of over 150 versatile product series offerings.
Sodium glucarate, produced commercially for the first time with Rivertop Renewables’ oxidation technology, has achieved REACH registration, opening the door for imports into Europe. Water treatment and detergent markets are expected to be among the first to see formulations with this novel chemical.
The 32nd International Exhibition for Fine and Speciality Chemicals, Chemspec Europe 2017, concluded after two successful exhibition days. International industry experts from the fine and speciality chemicals industry met at the Munich Trade Fair Centre for their major sourcing and networking event in Europe.
The 10th SpeChem China will be held on 30th August to 1st September 2017 in Shanghai, China. This professional event in the fine and specialty chemicals industry is expecting to attract business leaders and high-level speakers on the industry in China. Launched in 2008, Spechem China has focused on fine chemicals and specialty chemicals, enabling communication and cooperation within the industry, both in the domestic market in China and abroad. SpeChem is supported by the China Petroleum and Chemical Industry Federation (CPCIF), and generally attracts much attention and participation by global fine and specialty chemical enterprises.